Press "Enter" to skip to content

New patent for Genentech Inc drug ROZLYTREK

0
Copyright © DrugPatentWatch. Originally published at New patent for Genentech Inc drug ROZLYTREK

Annual Drug Patent Expirations for ROZLYTREK
Annual Drug Patent Expirations for ROZLYTREK

Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

This drug has one hundred and one patent family members in twenty-nine countries.

The generic ingredient in ROZLYTREK is entrectinib. One supplier is listed for this compound. Additional details are available on the entrectinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Genentech Inc drug ROZLYTREK
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions